.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

EC awards Allergan license to market bimatoprost/timolol solution

June 8, 2006

The European Commission (EC) granted Allergan a license to market bimatoprost/timolol ophthalmic solution (Ganfort) in the European Union. The once-daily combination product is indicated for the reduction of IOP in patients with open-angle glaucoma or ocular hypertension whose disease is insufficiently responsive to topical beta-blockers or prostaglandin analogues.